T. Seufferlein

Transforming growth factor beta1 treatment leads to an epithelial-mesenchymal transdifferentiation of pancreatic cancer cells requiring extracellular signal-regulated kinase 2 activation.

T. Seufferlein, T. Gress, G. Adler, 2001, Cancer research.

CD147 silencing inhibits lactate transport and reduces malignant potential of pancreatic cancer cells in in vivo and in vitro models

F. Oswald, T. Seufferlein, T. Gress, 2009, Gut.

In-vivo monitoring of acute DSS-Colitis using Colonoscopy, high resolution Ultrasound and bench-top Magnetic Resonance Imaging in Mice

T. Seufferlein, H. Metz, K. Mäder, 2015, European Radiology.

KOC is a novel molecular indicator of malignancy

T. Seufferlein, T. Gress, G. Adler, 2003, British Journal of Cancer.